Among the most-read product recall stories are those of amoxicillin, metformin, sodium bicarbonate Omnipod 5, and clopidogrel and atenolol.
In the first drug recall of 2022, Cranford, New Jersey-based Viona Pharmaceuticals is voluntarily recalling 23 lots of metformin hydrochloride extended-release tablets.
The FDA has released a final guidance document on November 18, stipulating minimum steps pharmacies that compound beta lactam oral antibiotic suspension products must take to mitigate the potential for cross-contamination with other products.
The ongoing amoxicillin shortage is impacting hospitals and pharmacies across the United States. New data from healthcare services firm Vizient is showing a 43% surge in demand for all amoxicillin products in the acute care setting from September to October.
This is second issue related to Omnipod 5. Insulet also had received 50 complaints related to the batteries of Omnipod DASH Personal Diabetes Manager.
Exela Pharma is recalling an additional 14 lots of sodium bicarbonate injection because of a broken vial.
In one lot, a bottle containing clopidogrel was mislabeled as atenolol. This lot was sold to AmerisourceBergen and McKesson.